NMMerchantiles Increases Stake in IOL Chemicals & Pharmaceuticals Ltd Through Share Acquisition
NMMerchantiles Limited has increased its equity shareholding in IOL Chemicals and Pharmaceuticals Limited following the acquisition of shares from two other entities. The transaction details indicate a notable rise in the company’s stake, bringing its holding to 21.88%.The acquisition was completed on June 25, 2026. NMMerchantiles acquired equity shares totaling 1,40,83,195 from M/s G Consultants and Fabricators Private Limited and 1,11,78,195 equity shares from M/s Synthorix Trading Limited.
Prior to this acquisition, NMMerchantiles held 5,01,31,650 equity shares in IOL Chemicals and Pharmaceuticals Limited, representing a stake of 17.08%. The transaction significantly expanded its holding.
The total number of shares acquired from both parties was reported as 25,262,390 shares. Following the acquisition, NMMerchantiles' total combined holdings reached 6,42,14,845 equity shares, which accounts for 21.88% of the company.
The financial metrics related to the acquisition and holding status are detailed below:
| Metric | Before Acquisition (NMMerchantiles Holding) | Post Acquisition (Total Holding) |
|---|---|---|
| Shares Carried by Voting Rights | 5,01,31,650 | 6,42,14,845 |
| Stake Percentage | 17.08% | 21.88% |
The target company's equity share capital was reported as 29,35,27,510 Equity Shares of Rs. 2 each before the acquisition. This figure remained consistent for both pre- and post-acquisition status reports regarding the total voting capital.
IOLCP Stock Price Movement
As of 12:39 PM, shares of IOL Chemicals and Pharmaceuticals Limited are rallying hard in live trading, currently clocking in at ₹139.8 as the stock breaches its 52-week high. This surge is underscored by significant intraday strength, with the equity hitting a peak of ₹142.45 amid robust buying interest across 7.10 million shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.